TargetMol

LXY3

Product Code:
 
TAR-TP3270
Product Group:
 
Peptides
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TP3270-10mg10 mgEnquire
Quantity:
TAR-TP3270-50mg50 mgEnquire
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Austria.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Bioactivity:
LXY3 (LXY2) is a VLA-3 blocking peptide that inhibits the interaction of neutrophil surface integrin α3β1 (VLA-3) with laminin in the basement membrane, thereby preventing neutrophil migration across the tumor vascular basement membrane barrier. LXY3 is employed to block the neutrophil-mediated release of nanoparticles from the perivascular pool into the tumor stroma and is frequently used for targeted imaging in breast cancer.
CAS Number:
1095009-44-1
Formula:
C32H43N11O15S2
Molwt:
885.88
Pathway:
Cytoskeletal Signaling
SMILES:
O=C1[C@]2(N(C[C@H](O)C2)C(=O)CNC(=O)[C@H](CC3=CC(N(=O)=O)=C(O)C=C3)NC(=O)CNC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](N)CSSC[C@H](C(N)=O)NC(=O)[C@H](CC(N)=O)N1)[H]
Target:
Integrin

Documents